PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27855360-3	2017	This study shows that the 3-benzyloxy-beta-nitrostyrene analogues are potent inhibitors of the MAO-B isoform with IC50 values in the nanomolar range (39-565 nM).	3-benzyloxy-beta-nitrostyrene	26-55	monoamine oxidase B	Homo sapiens	95-100	
27855360-5	2017	Since some of the 3-benzyloxy-beta-nitrostyrene analogues possess potencies that are comparable to that of the reversible inhibitor, safinamide (IC50 = 0.080 muM), it may be concluded that this class may be promising leads for the development of reversible and selective MAO-B inhibitors, that may be useful for the management of Parkinson"s disease.	3-benzyloxy-beta-nitrostyrene	18-47	monoamine oxidase B	Homo sapiens	271-276